BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 24, 2026
Breaking News: Ongoing coverage of the Ebola outbreakBreaking News: Ongoing coverage of the Ebola outbreakBreaking News: Ongoing coverage of the Ebola outbreak
Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic RSS Feed RSS

Nutrition 21 identifies isomer of CLA that improves glucose metabolism without insulin

Feb. 12, 2002

Takeda describes compounds for hyperlipidemia in recent patent

Feb. 7, 2002

Sakai to codevelop and market Theratechnologies' ThGRF peptide in Japan

Feb. 7, 2002

Encouraging results observed in phase IIa trial of AOD-9604 in obese patients

Feb. 7, 2002

Study finds oral contraceptives double the risk of first ischemic stroke

Feb. 7, 2002

Bio-Technology General initiates phase I study of Puricase in gout

Feb. 6, 2002

Potent hypoglycemic and hypolipidemic agent interacting with PPARgamma identified at Takeda

Feb. 6, 2002

Robust thermogenic responses elicited by new beta3-adrenoceptor agonists identified at GSK

Feb. 6, 2002

Quinazoline derivatives that act as NPY antagonists for eating disorders, etc.

Feb. 5, 2002

Forbes Medi-Tech initiates phase I trial of cholesterol-lowering pharmaceutical

Feb. 5, 2002
Previous 1 2 … 1382 1383 1384 1385 1386 1387 1388 1389 1390 … 1797 1798 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 23, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 23, 2026
  • Blue brain with computer chip

    Have brain-computer interfaces finally arrived?

    BioWorld
    More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
  • Nankai University and Accendatech present new majusculamide D derivatives

    BioWorld Science
    Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing